
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1061 | 885 | 1061 | 1258 | 1925 | - |
Fund Return | 6.06% | -11.55% | 6.06% | 7.95% | 13.99% | - |
Place in category | 10 | 178 | 10 | 6 | 5 | - |
% in Category | 6 | 87 | 6 | 2 | 3 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
S Horizon Global Technology Fund G2 | 291.12M | 3.70 | 15.32 | 18.00 | ||
S Horizon Global Technology Fund Hu | 354.76M | 3.68 | 15.01 | 17.69 | ||
S Horizon Global Technology Fund 1u | 13.47M | -2.71 | 14.40 | 16.43 | ||
S Horizon Global Technology Fund Iu | 399.24M | -2.71 | 14.40 | 16.44 | ||
Henderson Horizon Global Technology | 55.67M | 3.68 | 15.01 | 17.66 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Pictet Biotech Z USD | 1.25B | -0.94 | 7.69 | 3.16 | ||
Franklin Biotech Discovery Nacc | 95.4M | 1.89 | 0.99 | 1.49 | ||
Equities L Biotechnology Class R US | 1.3B | 3.48 | 8.71 | 5.94 | ||
LU0133359157 | 1.3B | 3.53 | 7.41 | 4.64 | ||
Equities L Biotechnology Class I US | 1.3B | 2.92 | 2.58 | 5.59 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Vertex | US92532F1003 | 6.98 | 488.34 | -2.33% | |
argenx ADR | US04016X1019 | 4.96 | 580.43 | +1.65% | |
Amgen | US0311621009 | 4.90 | 318.89 | -2.59% | |
Sarepta | US8036071004 | 4.14 | 100.71 | +1.02% | |
Ascendis Pharma AS | US04351P1012 | 4.03 | 145.63 | +5.39% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Strong Sell | Neutral |
Technical Indicators | Strong Sell | Strong Sell | Strong Sell |
Summary | Strong Sell | Strong Sell | Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review